Churg-Strauss syndrome epidemiology and demographics: Difference between revisions
No edit summary |
|||
| Line 7: | Line 7: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
The prevalence of Eosinophilic granulomatosis with polyangiitis | The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 13 per million person a year, with higher prevalences seen in Europeans.<ref name="pmid14872461">{{cite journal| author=Mahr A, Guillevin L, Poissonnet M, Aymé S| title=Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. | journal=Arthritis Rheum | year= 2004 | volume= 51 | issue= 1 | pages= 92-9 | pmid=14872461 | doi=10.1002/art.20077 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14872461 }} </ref> | ||
===Age=== | ===Age=== | ||
Revision as of 13:16, 18 November 2016
|
Churg-Strauss syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Churg-Strauss syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Churg-Strauss syndrome epidemiology and demographics |
|
Churg-Strauss syndrome epidemiology and demographics in the news |
|
Blogs on Churg-Strauss syndrome epidemiology and demographics |
|
Risk calculators and risk factors for Churg-Strauss syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3]
Overview
The prevalence of Eosinophilic granulomatosis with polyangiitis is estimated to be 10.7 per million person a year.
Epidemiology and Demographics
Prevalence
The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 13 per million person a year, with higher prevalences seen in Europeans.[1]
Age
The mean age at diagnosis is 50. The initial onset of symptoms may be 10-20 years earlier.
Gender
There is no gender predominance.
References
- ↑ Mahr A, Guillevin L, Poissonnet M, Aymé S (2004). "Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate". Arthritis Rheum. 51 (1): 92–9. doi:10.1002/art.20077. PMID 14872461.